Response to hepatitis B vaccination in patients with celiac disease

被引：40

作者：

Ahishali, Emel ^{[1
]}

Boztas, Gungor ^{[1
]}

Akyuz, Filiz ^{[1
]}

Ibrisim, Duygu ^{[1
]}

Poturoglu, Sule ^{[1
]}

Pinarbasi, Binnur ^{[1
]}

Ozdil, Sadakat ^{[1
]}

Mungan, Zeynel ^{[1
]}

机构：

[1] Istanbul Univ, Dept Gastroenterohepatol, Istanbul Fac Med, TR-34390 Istanbul, Turkey

来源：

DIGESTIVE DISEASES AND SCIENCES | 2008年 / 53卷 / 08期

关键词：

celiac disease; hepatitis B; vaccination;

D O I：

10.1007/s10620-007-0128-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Abnormal immune response to gliadin, genetic, and environmental factors play a role in the pathogenesis of celiac disease (CD). Non-responsiveness to hepatitis B virus (HBV) vaccination is related to genetic features. Certain human leukocyte antigen (HLA) genotypes are more prevalent among non-responders to HBV vaccination. There is also a strong relationship between CD and these HLA genotypes. This study investigates the relationship between CD and non-responsiveness to HBV vaccination, with an emphasis on genotypic co-incidence. No statistically significant difference was noted between the ages and gender of CD patients and control subjects. Baseline serum IgA, IgM, and IgG levels of all CD patients were normal. Responsiveness to HBV vaccination was observed in 17 (68%) CD patients and all (100%) control subjects (P = 0.006). In conclusion, CD should also be sought in unresponders to HBV vaccine who are not immunosuppressed.

引用

页码：2156 / 2159

页数：4

共 50 条

[41] Commentary on: Are hepatitis B virus and celiac disease linked?
Prasad, Kaushal Kishor
Sharma, Arun K.
Nain, Chander K.
Singh, Kartar
HEPATITIS MONTHLY, 2011, 11 (01) : 45 - 46
[42] Prevalence of celiac disease in patients with hepatitis B and C virus related cirrhosis and cryptogenic liver cirrhosis.
Balkan, Ayhan
Gulsen, Murat Taner
Er, Ramazan Erdem
Yildirim, Abdullah Emre
Konduk, Bugra Tolga
Barutcu, Sezgin
BIOMEDICAL RESEARCH-INDIA, 2017, 28 (08): : 3736 - 3741
[43] Long-term response rates of successful hepatitis B vaccination in HIV-infected patients
Lopes, Vania Baptista
Hassing, Robert J.
de Vries-Sluijs, Theodora E. M. S.
el Barzouhi, Abdel
Hansen, Bettina E.
Schutten, Martin
de Man, Robert A.
van der Ende, Marchina E.
VACCINE, 2013, 31 (07) : 1040 - 1044
[44] Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination
Williams, IT
Goldstein, ST
Tufa, J
Tauillii, S
Margolis, HS
Mahoney, FJ
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (02) : 157 - 163
[45] Modulation of immune response to rDNA hepatitis B vaccination by psychological stress
Jabaaij, L
vanHattum, J
Vingerhoets, AJJM
Oostveen, FG
Duivenvoorden, HJ
Ballieux, RE
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1996, 41 (02) : 129 - 137
[46] Hepatitis B vaccination in haemodialysis patients: A randomized clinical trial
Bock, Marilene
Barros, Elvino
Veronese, Francisco J. V.
NEPHROLOGY, 2009, 14 (03) : 267 - 272
[47] Low seroconversion with hepatitis B vaccination in peritoneal dialysis patients
Khan, AN
Bernardini, J
Rault, RM
Piraino, B
PERITONEAL DIALYSIS INTERNATIONAL, 1996, 16 (04): : 370 - 373
[48] Missed opportunities for Hepatitis B vaccination among diabetic patients
Ozisik, Lale
Tanriover, Mine Durusu
Basaran, Nursel Calik
Oz, S. Gul
Unal, Serhat
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (12) : 2806 - 2810
[49] Serologic Response to Hepatitis B Vaccination Among Lung Transplantation Candidates
Galar, Alicia
Engelson, Brian A.
Kubiak, David W.
Licona, Jose H.
Boukedes, Steve
Goldberg, Hilary J.
Baden, Lindsey R.
Marty, Francisco M.
Issa, Nicolas C.
TRANSPLANTATION, 2014, 98 (06) : 676 - 679
[50] Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease
Kwon, Joshua Y.
Daoud, Nader D.
Hashash, Jana G.
Picco, Michael F.
Farraye, Francis A.
INFLAMMATORY BOWEL DISEASES, 2023, 29 (02) : 254 - 259

← 1 2 3 4 5 →